What are the standard surveillance definitions for hospital‑acquired infections, including HAI, CLABSI, CAUTI, VAP, SSI, and non‑line‑associated BSI?

Hospital-Acquired Infection Surveillance Definitions

Standard surveillance definitions for hospital-acquired infections follow CDC/NHSN criteria, with HAI defined as infections occurring ≥48 hours after hospital admission, VAP occurring ≥48-72 hours after intubation, and device-associated infections (CLABSI, CAUTI) requiring specific clinical, microbiological, and temporal criteria for classification.

Core Temporal Thresholds

All hospital-acquired infections share a fundamental requirement: the infection must not be present or incubating at the time of hospital admission or device insertion 1.

Hospital-Acquired Pneumonia (HAP)

• Non-ventilator HAP: Occurs after 48 hours of hospital stay 2
• Ventilator-Associated Pneumonia (VAP): Arises 48-72 hours after endotracheal intubation 1
• Early vs. Late classification: Early pneumonia occurs <5 days from admission; late pneumonia ≥5 days 2

Diagnostic Criteria for HAP/VAP

The 2018 French guidelines 2 specify a three-component algorithm:

Radiological Component:

• Two successive chest radiographs showing new or progressive lung infiltrates
• Single radiograph sufficient if no underlying heart/lung disease

Plus at least ONE systemic sign:

• Temperature >38.3°C without other cause
• Leukocytes <4,000/mm³ or >12,000/mm³

Plus at least TWO respiratory signs:

• Purulent sputum
• Cough or dyspnea
• Declining oxygenation, increased oxygen requirement, or need for respiratory assistance

Central Line-Associated Bloodstream Infection (CLABSI)

3 defines CLABSI with specific requirements:

Device Criteria:

• Central line (vascular access device terminating at or near the heart or great vessels) in place during the 48-hour period before BSI development
• If time interval >48 hours, compelling evidence required linking infection to the line

Microbiological Criteria (Age ≥1 year):

• Recognized pathogen cultured from ≥1 blood culture, OR
• Common skin contaminant cultured from ≥2 blood cultures drawn on separate occasions, OR
• Common skin contaminant from ≥1 blood culture with IV line present AND physician institutes appropriate antimicrobial therapy, OR
• Positive antigen test on blood with signs/symptoms not related to another site

Clinical Criteria:

• Fever (>38°C), hypotension (systolic <90 mmHg), or oliguria (<20 mL/hr)
• No other recognized infection source

Catheter-Associated Urinary Tract Infection (CAUTI)

While specific CAUTI definitions are not detailed in the provided guidelines, surveillance requires 4, 5, 6:

• Urinary catheter in place during the 48-hour period before infection onset
• Clinical signs (fever, suprapubic tenderness, costovertebral angle pain/tenderness)
• Microbiological evidence meeting quantitative thresholds
• No alternative source of infection

Critical Pitfall: Different surveillance systems (CDC vs. other national systems) may have varying microbiological thresholds and clinical criteria, leading to significantly different incidence rates 7. The Israeli Ministry of Health criteria, for example, yielded 22% higher HAUTI rates compared to CDC definitions, with only 83% agreement for all HAUTI cases.

Surgical Site Infection (SSI)

8 categorizes SSI into three types:

Superficial Incisional SSI

• Occurs within 30 days of surgery
• Involves only subcutaneous tissue between skin and fascia
• Requires at least ONE of:
  • Purulent incisional drainage
  • Positive culture from aseptically obtained fluid/tissue
  • Local signs (pain, tenderness, swelling, erythema) after surgeon opens incision (unless culture negative)
  • Surgeon or physician diagnosis

Deep Incisional SSI

• Within 30 days (or 1 year if prosthetic material placed)
• Involves deep soft tissues (fascial/muscle layers)

Organ/Space SSI

• Within 30 days (or 1 year if prosthetic material placed)
• Involves any anatomic site other than incision that was opened/manipulated during surgery

Important Timing Consideration: SSIs rarely occur within the first 48 hours post-surgery. Fever during this period usually has noninfectious causes. Early SSIs (<48 hours) are almost always due to S. pyogenes or Clostridium species 8.

Non-Line-Associated Bloodstream Infection (BSI)

3 defines BSI without central line association using identical microbiological criteria as CLABSI but without device attribution:

For patients ≥1 year:

• Recognized pathogen from ≥1 blood culture, OR
• Common skin contaminant from ≥2 separate blood cultures, OR
• Positive blood antigen test with clinical signs not related to another site

Clinical Sepsis (when blood culture not done or negative):

• Fever (>38°C), hypotension (systolic <90 mmHg), or oliguria (<20 mL/hr)
• No apparent infection at another site
• Physician institutes sepsis treatment

Key Surveillance Considerations

Microbiological Confirmation: For HAP/VAP, pathogens are isolated in approximately 70% of suspected cases 2. Common organisms include Enterobacteriaceae, S. aureus, P. aeruginosa, and A. baumannii. Early pneumonia typically involves methicillin-susceptible S. aureus, S. pneumoniae, and H. influenzae 2.

Surveillance vs. Clinical Definitions: 9 emphasizes that surveillance definitions overestimate true infection incidence because they include all BSIs when other sites are excluded, capturing secondary BSIs from undocumented sources (surgical sites, intra-abdominal infections, pneumonia, UTIs). Clinical adjudication panels that veto events meeting surveillance definitions compromise data validity and should be avoided.

Standardization Challenges: 10 identified substantial variation across 7 international surveillance frameworks, with 52 different surveillance definitions and 208 diagnostic elements. Pneumonia definitions showed the greatest heterogeneity. Device/procedure association and temporal thresholds were most consistent, while microbiological requirements varied significantly.